"Overcoming barriers to innovation - our learning so far" - A presentation by Dr Axel Heitmueller, Managing Director of Imperial College Health Partners, to the London Clinical Senate on 13 October 2016.
2. INNOVATION
Innovation can be defined as the successful
conversion of new concepts and
knowledge into new products, services, or
processes that deliver new value
=
CHANGE
3. WHAT’S WRONG WITH US?
No shortage of spontaneous inventions and small
scale innovation – NHS R&D second to none
Scaling out of single sites and academic papers
remains challenging
BUT no real comparative evidence on relative NHS
performance
[How many successfully scaled innovations
can you name?
#9539 www.slido.com]
4. “A NEW SCIENTIFIC TRUTH DOES
NOT TRIUMPH BY CONVINCING ITS
OPPONENTS AND MAKING THEM
SEE THE LIGHT, BUT RATHER
BECAUSE ITS OPPONENTS
EVENTUALLY DIE, AND A NEW
GENERATION GROWS UP THAT IS
FAMILIAR WITH IT.”
MAX PLANCK | GERMAN THEORETICAL PHYSICIST
6. WHAT ARE BARRIERS
TO DRIVING CHANGE?
BRITISH MEDICAL JOURNAL, "LOOKING IN THE WRONG PLACES: WHY TRADITIONAL SOLUTIONS TO THE DIFFUSIO
N OF INNOVATION WILL NOT WORK", AXEL HEITMUELLER, ADRIAN BULL, SHIRLENE OH, FEBRUARY 2016
Research funding focused on academic
rather than frontline impact
Organisations do not reward "ideas-
stealing"
Health professionals not supported to
identify need and scout for suitable solutions
or utilise change methodology
No clear regulatory pathway into the market for
digital innovations and lack of scale
Budgeting structures divorce future savings
from current investment costs
Very limited contestability of services
7. TRADITIONAL SOLUTIONS
DON'T WORK
Funding support
primarily given
to “supply” side –
something will
stick
Top-down ‘push’
of proven
innovations e.g.
ITAPP, NICE
TAs
Busy clinicians
given “change” as
an add-on to their
day job.
8. CASE STUDY: PAN LONDON
ATRIAL FIBRILLATION (AF)
PROJECT
Acute stroke care considered to be second to none
in London – but prevention has significant gaps
70,000 patients with AF are not diagnosed
Adherence to NICE best practice is extremely
variable and our data suggests that 2000 strokes
and 500 deaths could be avoided
A minority of patients dying from stroke are on the
right medication
9. How we delivered change
Barrier How we tackled them
Lack of appreciation of the
scale of problem
Limited accountability for
outcomes
Deep data analysis to understand
the challenge
Design of meaningful QOF
Uneven capability – GPs
varied understanding of
new anti coagulants
(DOACs)
Lack of funding – CCGs
reluctant to invest upfront in
invest to save schemes
Pop-up educational workshops
to raise awareness of DOAC
technological innovations
Lack of time – GPs don’t
have time to deliver
comprehensive care
Backfilled clinical champions to
drive change and provide
credibility
10. “Give a man a fish and you feed him for a
day; teach a man to fish and you feed him
for a lifetime”
ANNE ISABELLA THACKERAY RITCHIE'S (1837–1919)
NOVEL, MRS. DYMOND (1885)
11. But true disruption may
come from elsewhere…
…patients and cares
in a democratised
medical model
Stolen from Tony Young (with permission)